Article 6FV5Z David says ketamine was a ‘lifesaver’ for his depression. So why are many in Australia missing out?

David says ketamine was a ‘lifesaver’ for his depression. So why are many in Australia missing out?

by
Natasha May
from Science | The Guardian on (#6FV5Z)

A lack of commercial incentives to get the drug approved for treatment-resistant depression means people cannot afford it

After being abused as a child, David spent decades searching for a treatment for his depression and anxiety. Like many people with treatment-resistant depression, he was cycled by psychiatrists through a variety of drugs and therapies, but David - who asked for only his first name to be used - said he remained debilitated".

Then in October 2021, at age 64, he began a fortnightly ketamine treatment - and it proved to be a lifesaver".

Continue reading...
External Content
Source RSS or Atom Feed
Feed Location http://feeds.theguardian.com/theguardian/science/rss
Feed Title Science | The Guardian
Feed Link https://www.theguardian.com/science
Feed Copyright Guardian News and Media Limited or its affiliated companies. All rights reserved. 2025
Reply 0 comments